Published in Chest on December 01, 2007
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 2.19
An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med (2013) 1.66
Impact of the lung allocation score on survival beyond 1 year. Am J Transplant (2014) 1.57
Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med (2015) 1.45
Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant (2013) 1.42
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant (2010) 1.09
The lung allocation score and survival in lung transplant candidates with chronic obstructive pulmonary disease. Lung (2009) 0.86
Personalized medicine: applying 'omics' to lung fibrosis. Biomark Med (2012) 0.84
Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients. J Heart Lung Transplant (2015) 0.78
Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era. J Thorac Cardiovasc Surg (2011) 0.76
Lung Transplantation in Patients with High Lung Allocation Scores in the US: Evidence for the Need to Evaluate Score Specific Outcomes. J Transplant (2015) 0.75
Waiting narratives of lung transplant candidates. Nurs Res Pract (2013) 0.75
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med (2007) 10.13
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A (2007) 5.95
Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med (2008) 5.82
Hospital volume and the outcomes of mechanical ventilation. N Engl J Med (2006) 5.67
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2012) 5.37
Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA (2010) 4.36
Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med (2007) 4.34
The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med (2005) 4.25
Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly. N Engl J Med (2009) 4.23
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College [corrected] of Critical Care Medicine. Crit Care Med (2008) 3.85
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med (2011) 3.85
Expanding the paradigm of the physician's role in surrogate decision-making: an empirically derived framework. Crit Care Med (2010) 3.54
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 3.49
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 3.23
Family satisfaction with family conferences about end-of-life care in the intensive care unit: increased proportion of family speech is associated with increased satisfaction. Crit Care Med (2004) 3.18
Clinician statements and family satisfaction with family conferences in the intensive care unit. Crit Care Med (2006) 3.08
Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med (2010) 3.05
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med (2004) 2.97
Prognostication during physician-family discussions about limiting life support in intensive care units. Crit Care Med (2007) 2.96
Pulmonary fibrosis associated with aluminum trihydrate (Corian) dust. N Engl J Med (2014) 2.88
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
The burden of influenza-associated critical illness hospitalizations. Crit Care Med (2014) 2.84
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA (2010) 2.75
Quality of dying in the ICU: is it worse for patients admitted from the hospital ward compared to those admitted from the emergency department? Intensive Care Med (2014) 2.71
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med (2009) 2.65
Decisions to limit life-sustaining treatment for critically ill patients who lack both decision-making capacity and surrogate decision-makers. Crit Care Med (2006) 2.61
Toward shared decision making at the end of life in intensive care units: opportunities for improvement. Arch Intern Med (2007) 2.56
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.54
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea. Intensive Care Med (2012) 2.52
Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med (2002) 2.50
Models for structuring a clinical initiative to enhance palliative care in the intensive care unit: a report from the IPAL-ICU Project (Improving Palliative Care in the ICU). Crit Care Med (2010) 2.49
Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The Consensus for Worldwide End-of-Life Practice for Patients in Intensive Care Units (WELPICUS) study. Am J Respir Crit Care Med (2014) 2.46
Quality indicators for end-of-life care in the intensive care unit. Crit Care Med (2003) 2.42
Evaluation of a standardized order form for the withdrawal of life support in the intensive care unit. Crit Care Med (2004) 2.42
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med (2010) 2.40
Refinement, scoring, and validation of the Family Satisfaction in the Intensive Care Unit (FS-ICU) survey. Crit Care Med (2007) 2.34
Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med (2010) 2.28
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Barriers and facilitators to end-of-life care communication for patients with COPD. Chest (2005) 2.23
Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS One (2011) 2.21
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
Using the medical record to evaluate the quality of end-of-life care in the intensive care unit. Crit Care Med (2008) 2.16
Management of the critically ill patient with severe acute pancreatitis. Crit Care Med (2004) 2.16
Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med (2014) 2.15
Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med (2005) 2.13
Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol (2012) 2.08
Family satisfaction in the ICU: differences between families of survivors and nonsurvivors. Chest (2007) 2.08
An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc (2013) 2.08
Abandonment at the end of life from patient, caregiver, nurse, and physician perspectives: loss of continuity and lack of closure. Arch Intern Med (2009) 2.03
Point: the ethics of unilateral "do not resuscitate" orders: the role of "informed assent". Chest (2007) 2.02
Choosing and using screening criteria for palliative care consultation in the ICU: a report from the Improving Palliative Care in the ICU (IPAL-ICU) Advisory Board. Crit Care Med (2013) 1.97
Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr (2002) 1.96
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med (2005) 1.90
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis (2001) 1.85
Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest (2002) 1.83
Medicine residents' self-perceived competence in end-of-life care. Acad Med (2009) 1.82
Comparing clinician ratings of the quality of palliative care in the intensive care unit. Crit Care Med (2011) 1.81
Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life". JAMA (2006) 1.80
Establishing an evidence base for physician-family communication and shared decision making in the intensive care unit. Crit Care Med (2006) 1.80
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2014) 1.80
Determinants of medical students' perceived preparation to perform end-of-life care, quality of end-of-life care education, and attitudes toward end-of-life care. J Palliat Med (2010) 1.79
Measuring and improving the quality of dying and death. Ann Intern Med (2003) 1.78
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med (2003) 1.77
Factors associated with nurse assessment of the quality of dying and death in the intensive care unit. Crit Care Med (2004) 1.77
Association of depression and life-sustaining treatment preferences in patients with COPD. Chest (2005) 1.77
Predictors of symptoms of posttraumatic stress and depression in family members after patient death in the ICU. Chest (2009) 1.74
Hospital variation and temporal trends in palliative and end-of-life care in the ICU. Crit Care Med (2013) 1.70
Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review. Crit Care Med (2015) 1.68
A story of success: continuous quality improvement in cystic fibrosis care in the USA. Thorax (2011) 1.68
Families with limited English proficiency receive less information and support in interpreted intensive care unit family conferences. Crit Care Med (2009) 1.68
A scenario-based, randomized trial of patient values and functional prognosis on intensivist intent to discuss withdrawing life support. Crit Care Med (2014) 1.66
Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. Chest (2008) 1.65
Development of a predictive model for long-term survival after lung transplantation and implications for the lung allocation score. J Heart Lung Transplant (2010) 1.64
Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med (2012) 1.64
Spiritual care of families in the intensive care unit. Crit Care Med (2007) 1.62
Withdrawing life support and resolution of conflict with families. BMJ (2002) 1.62
Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis. Chest (2012) 1.60
Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest (2005) 1.60
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med (2012) 1.59
Integrating palliative care in the surgical and trauma intensive care unit: a report from the Improving Palliative Care in the Intensive Care Unit (IPAL-ICU) Project Advisory Board and the Center to Advance Palliative Care. Crit Care Med (2012) 1.58
Development of an e-mail database of US intensive care physicians. J Crit Care (2007) 1.58
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54
Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia. Respiration (2009) 1.54
Quality of dying and death in two medical ICUs: perceptions of family and clinicians. Chest (2005) 1.53
Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med (2011) 1.53
Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol (2010) 1.53